Prokineticin 1 expression in gastrointestinal tumors

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Prokineticin 1 (PROK1) is a secreted protein with diverse biological functions.
• Its role in gastrointestinal (GI) malignancies remains largely unexplored.

Purpose of the Study:

• To investigate the expression patterns of PROK1 in human GI carcinomas.
• To explore the potential association between PROK1 expression and clinicopathological features, including angiogenesis.

Main Methods:

• Immunohistochemistry was employed to detect PROK1 expression in human GI cancer cell lines and primary tumor tissues.
• PROK1 expression levels were analyzed in relation to the microvessel density in primary GI lesions.

Main Results:

• PROK1 expression was detected in various GI cancer cell lines.
• PROK1 was found in 31.6% of colorectal, 34.5% of gastric, and 50% of small intestine primary cancers, but not in healthy GI mucosa.
• PROK1-positive lesions exhibited significantly higher vascularity compared to PROK1-negative lesions, particularly in advanced cancers.

Conclusions:

• PROK1 expression is a feature of GI cancers.
• PROK1 expression correlates with increased angiogenesis.
• PROK1 may play a role in the progression and malignancy of GI cancers.